OW 2025 4 - 7 November 2025

Efficacy of oral semaglutide 25 mg in people with overweight or obesity and poor physical function

Authors :

Domenica Rubino¹; Oscar Birkhan²; W. Timothy Garvey³; Ildiko Lingvay⁴; Naveen Rathor²; Chaithra Shaji⁵; Sean Wharton^6,7,8,9

Affiliations

View Details Hide Details

{{ getPageNum(PDFPage) }}

Download poster (.pdf)

Download infographic (.pdf)

Keywords

Obesity

Congress poster

GLP-1 RA

Semaglutide (oral)

PHASE 3 (RCT)